CARCINOMA, NEUROENDOCRINE
Clinical trials for CARCINOMA, NEUROENDOCRINE explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear
Sign up with your email to follow new studies for CARCINOMA, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug target for rare cancers enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in adults with rare cancers of the digestive tract, pancreas, lungs, or adrenal glands. The main goal is to find the safest dose and see if the drug can shrink tumors. Participants receive the drug through an IV every 3 week…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Gene-Guided drug dosing could improve neuroendocrine cancer treatment
Disease control Recruiting nowThis study aims to see if adjusting the dose of the drug belinostat based on a person's genetic makeup can make treatment safer and more effective for high-grade neuroendocrine carcinomas. About 60 adults with this type of cancer will receive belinostat along with two other chemo…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Scientists launch lifelong study to unravel mysteries of rare neuroendocrine cancers
Knowledge-focused Recruiting nowThis study follows 300 adults with neuroendocrine tumors (including adrenocortical carcinoma) over their lifetime to understand how these rare cancers behave. Participants provide blood, urine, and tumor samples, and have yearly check-ups. The goal is to gather information and sa…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC